Suven Life Sci
100% of moneycontrol users recommend buying Suven Life Sci.
What's your call on Suven Life Sci today?
Read 3 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||3200.60||-0.88||3353.85||2420.00||54,527.29|
|Mar' 14||Dec' 13||Jun' 13||Mar' 13|
|Scheme||No. of Shares|
|IDFC Equity Opportunity - Series 1 - Direct Plan (Dividend Payout)||478,845|
|IDFC Equity Opportunity - Series 1 - Regular (Dividend Payout)||30,523|
National Buildings Constr Recommended on Jul 14th 2014
Recommended price 396.00 | Peak from reco 767.50 93.69%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Suven Life Sci is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 2,121.61 crore.The company has reported a standalone sales of Rs 141.53 crore and a Net Profit of Rs 34.74 crore for the quarter ended Jun 2014.
The company management includes Venkateswarlu Jasti - Chairman & CEO, Sudha Rani Jasti - Whole Time Director, M R Naidu - Director, K V Raghavan - Director, D G Prasad - Director, Syed E Hasnain - Director, M Gopala Krishna - Director.
It is listed on the BSE with a BSE Code of 530239 and the NSE with an NSE Code of SUVEN.
Its Registered office is at 8-2-334, SDE Serene Chambers, 6th Floor, Road No. 5,,Avenue 7, Hyderabad,Telangana - 500034.
Their Registrars are Karvy Computershare Private Ltd.